BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of Natus Medical Inc. ("Natus" or the "Company") (NASDAQ: BABY) concerning the Company and its officers’ possible violations of federal securities laws. Law Offices of Howard G. Smith is preparing a lawsuit on behalf of injured investors.
Natus designs, manufactures and markets newborn care and neurology healthcare products and services worldwide. The investigation concerns whether the Company adequately disclosed the risk that certain key government supply contracts would be cancelled and thereby cause a material decline in the Company’s revenues and profitability. In addition, Company insiders, including CEO Jim Hawkins, sold a significant amount of shares immediately prior to Company disclosures that certain revenue expectations would not be met.
On April 4, 2016, Natus announced its preliminary revenue for the quarter ended March 31, 2016. CEO Hawkins announced that due to, “pushouts of key orders in both our international and domestic markets, revenue for the first quarter of 2016 is now weaker than expected.” On this news, shares of Natus fell $7.80 per share, or over 24%, to close on April 4, 2016 at $31.84.
If you purchased Natus securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.